April 30, 2026

Uncategorized

Lilly says weight loss drug cuts heart failure risk by 38% in trial

Team Metabolic Health Trial results show Eli Lilly’s (LLY.N), opens new tab weight loss drug Zepbound reduces the risk of hospitalization, death…

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

FP Explainers  Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide…